118 related articles for article (PubMed ID: 33573398)
1. A prospective longitudinal study investigating outcomes including patient-reported outcome measures after surgery for metastatic bone disease.
Downie S; Stillie A; Moran M; Sudlow C; Simpson AHRW
Bone Jt Open; 2021 Feb; 2(2):79-85. PubMed ID: 33573398
[TBL] [Abstract][Full Text] [Related]
2. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported assessment of outcome after surgery for bone metastases.
Downie S; Stillie A; Moran M; Sudlow C; Simpson H
Orthop Rev (Pavia); 2021 Mar; 13(1):9062. PubMed ID: 33953891
[TBL] [Abstract][Full Text] [Related]
4. Early Improvement in Pain and Functional Outcome but Not Quality of Life After Surgery for Metastatic Long Bone Disease.
Nooh A; Goulding K; Isler MH; Mottard S; Arteau A; Dion N; Turcotte R
Clin Orthop Relat Res; 2018 Mar; 476(3):535-545. PubMed ID: 29529637
[TBL] [Abstract][Full Text] [Related]
5. Decompression surgery for spinal metastases: a systematic review.
Bakar D; Tanenbaum JE; Phan K; Alentado VJ; Steinmetz MP; Benzel EC; Mroz TE
Neurosurg Focus; 2016 Aug; 41(2):E2. PubMed ID: 27476844
[TBL] [Abstract][Full Text] [Related]
6. Postoperative quality-of-life assessment in patients with spine metastases treated with long-segment pedicle-screw fixation.
Bernard F; Lemée JM; Lucas O; Menei P
J Neurosurg Spine; 2017 Jun; 26(6):725-735. PubMed ID: 28338450
[TBL] [Abstract][Full Text] [Related]
7. Chinese multicentre prospective registry of breast cancer patient-reported outcome-reconstruction and oncoplastic cohort (PRO-ROC): a study protocol.
Li L; Yang B; Li H; Yin J; Jin F; Han S; Liao N; Shi J; Ling R; Li Z; Ouyang L; Wang X; Fu P; Ouyang Z; Ma B; Wu X; Wang H; Liu J; Shao Z; Wu J
BMJ Open; 2019 Dec; 9(12):e032945. PubMed ID: 31843846
[TBL] [Abstract][Full Text] [Related]
8. Communication in surgical decision-making while managing metastatic bone disease: matching patient expectations with surgical goals.
Barton KI; Hazenbiller O; Freeman G; Kashluba K; Ball M; Aboutaha A; Puloski SKT; Monument MJ
Support Care Cancer; 2021 Feb; 29(2):1111-1119. PubMed ID: 32607597
[TBL] [Abstract][Full Text] [Related]
9. The Ankle Injury Management (AIM) trial: a pragmatic, multicentre, equivalence randomised controlled trial and economic evaluation comparing close contact casting with open surgical reduction and internal fixation in the treatment of unstable ankle fractures in patients aged over 60 years.
Keene DJ; Mistry D; Nam J; Tutton E; Handley R; Morgan L; Roberts E; Gray B; Briggs A; Lall R; Chesser TJ; Pallister I; Lamb SE; Willett K
Health Technol Assess; 2016 Oct; 20(75):1-158. PubMed ID: 27735787
[TBL] [Abstract][Full Text] [Related]
10. Complications of bone metastases from malignant melanoma.
Zekri J; Marples M; Taylor D; Kandukurti K; McParland L; Brown JE
J Bone Oncol; 2017 Sep; 8():13-17. PubMed ID: 28856087
[TBL] [Abstract][Full Text] [Related]
11. The British Orthopaedic Oncology Management (BOOM) audit.
Archer JE; Chauhan GS; Dewan V; Osman K; Thomson C; Nandra RS; Ashford RU; Cool P; ; Stevenson J
Bone Joint J; 2023 Oct; 105-B(10):1115-1122. PubMed ID: 37777202
[TBL] [Abstract][Full Text] [Related]
12. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
[TBL] [Abstract][Full Text] [Related]
13. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
[TBL] [Abstract][Full Text] [Related]
14. A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
Efficace F; Boccadoro M; Palumbo A; Petrucci MT; Cottone F; Cannella L; Zamagni E; Niscola P; Kyriakou C; Caravita T; Offidani M; Mandelli F; Cavo M
Health Qual Life Outcomes; 2018 Jun; 16(1):127. PubMed ID: 29914509
[TBL] [Abstract][Full Text] [Related]
15. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
[TBL] [Abstract][Full Text] [Related]
16. HORIZONS protocol: a UK prospective cohort study to explore recovery of health and well-being in adults diagnosed with cancer.
Foster C; Calman L; Richardson A; May CR; Rogers A; Smith PW
BMJ Open; 2019 Jul; 9(7):e029662. PubMed ID: 31350251
[TBL] [Abstract][Full Text] [Related]
17. Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial.
Bendixen M; Jørgensen OD; Kronborg C; Andersen C; Licht PB
Lancet Oncol; 2016 Jun; 17(6):836-844. PubMed ID: 27160473
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
